<DOC>
	<DOCNO>NCT00175929</DOCNO>
	<brief_summary>This trial evaluate efficacy safety brivaracetam ( dose 50 150 mg/day twice day administration ) add therapy subject focal epilepsy</brief_summary>
	<brief_title>A Study Brivaracetam Subjects With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<criteria>Wellcharacterized focal epilepsy epileptic syndrome accord International League Against Epilepsy ( ILAE ) classification Subjects history partial onset seizure Subjects least 4 partial onset seizure Baseline period least 2 partial onset seizure per month 3 month precede Visit 1 Subjects uncontrolled treat 1 2 concomitant Antiepileptic drug ( ) AED ( ) stable Male/ female subject 16 65 year , inclusive . Subjects 18 year may include legally permit ethically accepted Seizure type IA nonmotor seizure type History presence seizure occur clustered pattern History cerebrovascular accident ( CVA ) Presence sign suggest rapidly progress brain disorder brain tumor</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Focal Epilepsy</keyword>
	<keyword>Partial Onset Seizures</keyword>
	<keyword>Brivaracetam</keyword>
</DOC>